Inventor
THOMAS ABRAHAM
IN41 patents
⚠️ This page may combine multiple inventors who share the name “THOMAS ABRAHAM”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GLENMARK PHARMACEUTICALS SA
20 patentsUS7205323B2Apr 17, 2007
Dipeptidyl peptidase IV inhibitors pharmaceutical compositions containing them, and process for their preparation
GLENMARK PHARMACEUTICALS SA8 citations71
US7538128B2May 26, 2009
Dipeptidyl peptidase IV inhibitors, process for their preparation and compositions containing them
GLENMARK PHARMACEUTICALS SA3 citations59
US7951814B2May 31, 2011
Quinazolinedione derivatives as TRPA1 modulators
GLENMARK PHARMACEUTICALS SA4 citations58
US10988467B2Apr 27, 2021
Compounds as ROR gamma modulators
GLENMARK PHARMACEUTICALS SA0 citations57
US8349846B2Jan 8, 2013
Fused pyrimidine derivatives as TRPV3 modulators
GLENMARK PHARMACEUTICALS SA2 citations56
US7524844B2Apr 28, 2009
Dipeptidyl peptidase IV inhibitors, process for their preparation and compositions containing them
GLENMARK PHARMACEUTICALS SA1 citations50
US9474758B2Oct 25, 2016
Thienopyrimidinedione derivatives as TRPA1 modulators
GLENMARK PHARMACEUTICALS SA0 citations49
US8987278B2Mar 24, 2015
Thienopyrimidinedione derivatives as TRPA1 modulators
GLENMARK PHARMACEUTICALS SA1 citations49
US9073955B2Jul 7, 2015
2-amino-4-arylthiazole compounds as TRPA1 antagonists
GLENMARK PHARMACEUTICALS SA0 citations48
US8889862B2Nov 18, 2014
2-amino-4-arylthiazole compounds as TRPA1 antagonists
GLENMARK PHARMACEUTICALS SA0 citations48
US10344024B2Jul 9, 2019
Compounds as ROR gamma modulators
GLENMARK PHARMACEUTICALS SA0 citations47
US9975887B2May 22, 2018
Compounds as ROR gamma modulators
GLENMARK PHARMACEUTICALS SA0 citations47
US9000159B2Apr 7, 2015
Fused pyrimidine-dione derivatives as TRPA1 modulators
GLENMARK PHARMACEUTICALS SA1 citations47
US10336688B2Jul 2, 2019
Carbocyclic compounds as ROR gamma modulators
GLENMARK PHARMACEUTICALS SA0 citations46
US10189775B2Jan 29, 2019
Carbocyclic compounds as ROR gamma modulators
GLENMARK PHARMACEUTICALS SA0 citations46
US9682977B2Jun 20, 2017
Bicyclic heteroaryl indole analogues useful as ROR gamma modulators
GLENMARK PHARMACEUTICALS SA1 citations45
US7893103B2Feb 22, 2011
Processes for the preparation of DPP IV inhibitors
GLENMARK PHARMACEUTICALS SA0 citations43
US9458173B2Oct 4, 2016
Amides of 2-amino-4-arylthiazole compounds and their salts
GLENMARK PHARMACEUTICALS SA0 citations41
US8344010B2Jan 1, 2013
Fused imidazole derivatives as TRPV3 antagonist
GLENMARK PHARMACEUTICALS SA0 citations35
US9718817B2Aug 1, 2017
Aryl and heteroaryl ether compounds as ROR gamma modulators
GLENMARK PHARMACEUTICALS SA0 citations30
COMCAST CABLE COMM LLC
6 patentsUSD947703SApr 5, 2022
Doorbell
COMCAST CABLE COMM LLC6 citations85
USD947702SApr 5, 2022
Doorbell
COMCAST CABLE COMM LLC12 citations85
USD947704SApr 5, 2022
Doorbell
COMCAST CABLE COMM LLC9 citations85
USD947701SApr 5, 2022
Doorbell
COMCAST CABLE COMM LLC5 citations73
US11575858B2Feb 7, 2023
Video device with electromagnetically reflective elements
COMCAST CABLE COMM LLC3 citations72
US12531968B2Jan 20, 2026
Video device with electromagnetically reflective elements
COMCAST CABLE COMM LLC0 citations62
KUMAR SUKEERTHI
3 patentsUS8507503B2Aug 13, 2013
Thienopyrimidinedione derivatives as TRPA1 modulators
KUMAR SUKEERTHI13 citations80
US8592398B2Nov 26, 2013
2-amino-4-arylthiazole compounds as TRPA1 antagonists
KUMAR SUKEERTHI8 citations79
US8575178B2Nov 5, 2013
Isothiazolo-pyrimidinedione derivatives as TRPA1 modulators
KUMAR SUKEERTHI5 citations70